NCT01916109 Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer Status TERMINATED Phase PHASE2
NCT01868087 Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study Status COMPLETED Phase EARLY_PHASE1
NCT01844947 Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract Status COMPLETED Phase PHASE1
NCT01840137 Trial of Prehabilitation in Vulnerable Patients Undergoing Cystectomy for Bladder Cancer Status COMPLETED Phase NA
NCT01836978 Prehabilitation to Enhance Postoperative Functional Capacity Following Radical Cystectomy Status COMPLETED Phase NA
NCT01824329 Prostate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder Cancer Status COMPLETED Phase PHASE2
NCT01812369 Perioperative Chemotherapy for Patients With Locally Advanced Bladder Cancer Status COMPLETED Phase PHASE3
NCT01780545 Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer Status COMPLETED Phase PHASE2
NCT01776138 Study of Outcomes After Surgery/Treatment to Treat Bladder Cancer Status COMPLETED Phase N/A
NCT01738815 Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer Status COMPLETED Phase EARLY_PHASE1
NCT01732107 Dovitinib in BCG Refractory Urothelial Carcinoma With FGFR3 Mutations or Over-expression Status TERMINATED Phase PHASE2
NCT01710293 Intervention Protocol for Automated Point-of-Care Surveillance of Outpatient Delays in Cancer Diagnosis Status WITHDRAWN Phase NA